Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage (original) (raw)

Nature volume 404, pages 787–790 (2000)Cite this article

Abstract

Diabetic hyperglycaemia causes a variety of pathological changes in small vessels, arteries and peripheral nerves1. Vascular endothelial cells are an important target of hyperglycaemic damage, but the mechanisms underlying this damage are not fully understood. Three seemingly independent biochemical pathways are involved in the pathogenesis: glucose-induced activation of protein kinase C isoforms2; increased formation of glucose-derived advanced glycation end-products3; and increased glucose flux through the aldose reductase pathway4. The relevance of each of these pathways is supported by animal studies in which pathway-specific inhibitors prevent various hyperglycaemia-induced abnormalities3,5,6,7. Hyperglycaemia increases the production of reactive oxygen species inside cultured bovine aortic endothelial cells8. Here we show that this increase in reactive oxygen species is prevented by an inhibitor of electron transport chain complex II, by an uncoupler of oxidative phosphorylation, by uncoupling protein-1 and by manganese superoxide dismutase. Normalizing levels of mitochondrial reactive oxygen species with each of these agents prevents glucose-induced activation of protein kinase C, formation of advanced glycation end-products, sorbitol accumulation and NFκB activation.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. National Diabetes Data Group Diabetes in America 2nd edn (National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health, USA, 1994).
    Google Scholar
  2. Koya,D. & King,G. L. Protein kinase C activation and the development of diabetic complications. Diabetes 47, 859–866 (1998).
    Article CAS Google Scholar
  3. Brownlee,M. Advanced protein glycosylation in diabetes and aging. Annu. Rev. Med. 46, 223–234 ( 1995).
    Article CAS Google Scholar
  4. Lee,A. Y., Chung,S. K. & Chung,S. S. Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens. Proc. Natl Acad. Sci. USA 92, 2780–2784 (1995).
    Article ADS CAS Google Scholar
  5. Ishii,H. et al. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 272, 728– 731 (1996).
    Article ADS CAS Google Scholar
  6. Park,L. et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nature Med. 4, 1025–1031 (1998).
    Article CAS Google Scholar
  7. Sima,A. A., Prashar,A., Zhang,W. X., Chakrabarti,S. & Greene, D. A. Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat. J. Clin. Invest. 85, 1410–1420 (1990).
    Article CAS Google Scholar
  8. Giardino,I., Edelstein,D. & Brownlee, M. BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J. Clin. Invest. 97, 1422– 1428 (1996).
    Article CAS Google Scholar
  9. Wallace,D. C. Diseases of the mitochondrial DNA. Annu. Rev. Biochem. 61, 1175–1212 (1992).
    Article CAS Google Scholar
  10. Trumpower,B. L. The protonmotive Q cycle. J. Biol. Chem. 265, 11409–11412 (1990).
    CAS PubMed Google Scholar
  11. Korshunov,S. S., Skulachev,V. P. & Starkov, A. A. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett. 416, 15–18 (1997).
    Article CAS Google Scholar
  12. Kwong,L. K. & Sohal,R. S. Substrate and site specificity of hydrogen peroxide generation in mouse mitochondria. Arch. Biochem. Biophys. 350, 118–126 ( 1998).
    Article CAS Google Scholar
  13. Ishihara,H. et al. Effect of Mitochondrial and/or cytosolic glycerol 3-phosphate dehydrogenase overexpression on glucose-stimulated insulin secretion from MIN6 and HIT cells. Diabetes 45, 1238– 1244 (1996).
    Article CAS Google Scholar
  14. Casteilla,L. et al. Stable expression of functional mitochondrial uncoupling protein in Chinese hamster ovary cells. Proc. Natl Acad. Sci. USA 87, 5124–5128 (1990).
    Article ADS CAS Google Scholar
  15. Manna,S. K. et al. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptotsis and activation of nuclear transcription factor-κB and activated protein-1. J. Biol. Chem. 273, 13245–13254 (1998).
    Article CAS Google Scholar
  16. Shinohara,M. et al. Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation product formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J. Clin. Invest. 101, 1142–1147 (1998).
    Article CAS Google Scholar
  17. Knight,R. J., Kofoed,K. F., Schelbert,H. R. & Buxton,D. B. Inhibition of glyceraldehyde-3-phosphate dehydrogenase in post-ischemic myocardium. Cardiovasc. Res. 32, 1016– 1023 (1996).
    Article CAS Google Scholar
  18. Chandra,A., Srivastava,S., Petrash,J. M., Bhatnagar,A. & Srivastava,S. K. Active site modification of aldose reductase by nitric oxide donors. Biochim. Biophys. Acta 1341, 217–222 ( 1997).
    Article CAS Google Scholar
  19. Pieper,G. M., Langenstroer,P. & Siebeneich, W. Diabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovasc. Res. 34, 145–156 (1997).
    Article CAS Google Scholar
  20. Pieper,G. M. & Haq,R. U. Activation of nuclear factor κB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C. J. Cardiovasc. Pharmacol. 30, 528–532 (1997).
    Article CAS Google Scholar
  21. Saeki,Y., Wataya-Kaneda,M., Tanaka, K. & Kaneda,Y. Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes. Gene Therapy 5, 1031–1037 (1998).
    Article CAS Google Scholar
  22. Saeki,Y. et al. Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): reciprocal effect of cationic lipid for in vitro and in vivo gene transfer. Human Gene Therapy 8, 2133–2144 (1997).
    Article CAS Google Scholar
  23. Yorek,M. A., Dunlap,J. A. & Lowe,W. L. Osmotic regulation of the Na+/myo-inositol cotransporter and postinduction normalization. Kidney Int. 55, 215–224 (1999).
    Article CAS Google Scholar
  24. Kurose,I. et al. CD18/ICAM-1-dependent oxidative NFκB activation leading to nitric oxide production in rat kupffer cells cocultured with syngeneic hepatoma cells. J. Clin. Invest. 99, 867 –878 (1997).
    Article CAS Google Scholar

Download references

Acknowledgements

We thank K. Preissner for his critical reading of the manuscript and M. Quon for his gift of plasmid pCIS-eGFP. This research was supported by grants from the National Institutes of Health (USA).

Author information

Author notes

  1. Takeshi Nishikawa
    Present address: Department of Medicine, Kumamoto University School of Medicine, Kumamoto, Japan

Authors and Affiliations

  1. Albert Einstein College of Medicine, Diabetes Research Centre, 1,300 Morris Park Ave, Bronx, 10461, New York, USA
    Takeshi Nishikawa, Diane Edelstein, Xue Liang Du, Sho-ichi Yamagishi, Takeshi Matsumura, Ida Giardino & Michael Brownlee
  2. Division of Gene Therapy Science Osaka University Medical School, Suita, 5650871, Osaka, Japan
    Yasufumi Kaneda
  3. Department of Internal Medicine University of Iowa, Iowa City, 52246, Iowa, USA
    Mark A. Yorek
  4. Department of Metabolic Diseases Central Research Division, Pfizer Inc., Groton, 06340, Connecticut, USA
    David Beebe & Peter J. Oates
  5. Justus-Liebig University III Medical Department, Giessen, D-35385, Germany
    Hans-Peter Hammes

Authors

  1. Takeshi Nishikawa
    You can also search for this author inPubMed Google Scholar
  2. Diane Edelstein
    You can also search for this author inPubMed Google Scholar
  3. Xue Liang Du
    You can also search for this author inPubMed Google Scholar
  4. Sho-ichi Yamagishi
    You can also search for this author inPubMed Google Scholar
  5. Takeshi Matsumura
    You can also search for this author inPubMed Google Scholar
  6. Yasufumi Kaneda
    You can also search for this author inPubMed Google Scholar
  7. Mark A. Yorek
    You can also search for this author inPubMed Google Scholar
  8. David Beebe
    You can also search for this author inPubMed Google Scholar
  9. Peter J. Oates
    You can also search for this author inPubMed Google Scholar
  10. Hans-Peter Hammes
    You can also search for this author inPubMed Google Scholar
  11. Ida Giardino
    You can also search for this author inPubMed Google Scholar
  12. Michael Brownlee
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toMichael Brownlee.

Rights and permissions

About this article

Cite this article

Nishikawa, T., Edelstein, D., Du, X. et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage.Nature 404, 787–790 (2000). https://doi.org/10.1038/35008121

Download citation

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.